Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( <i>ASPA</i> ) to the Human BrainChristopher G. Janson, Paola Leone, Scott McPhee et al.|Human Gene Therapy|2002Cited by 253
Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic DiseasesJacques P. Tremblay, John H. Wolfe, Helen M. Blau et al.|Molecular Therapy|2013Cited by 12